These molecules are expressed on T cells in the tumor microenvironment and inhibit T cell function [5], including well studied cytotoxic T-lymphocyte associated protein 4 (CTLA-4, also known as CD152) [93] and programmed cell death protein 1 (PD-1, also known as CD279) [94]. Here, PDCD1 is linked to neoplasm.